Abstract: A formula for use in treating skin aliments includes from about 20 to about 75 wt % emu oil; from about 0.10 to 33 wt % benzyl alcohol; from about 0.10 to about 33 wt % benzoin derivative; from about 0.2 to about 2 wt % allantoin; from about 0.25 to about 1.25 wt % methylparaben; from about 1.0 to about 13 wt % alkyl esters; and from about 0.01 to about 0.30 wt % propylparaben. The formula can be applied to skin of animals or humans with skin ailments. The formula can be applied is various manners, such as through an enhanced oil, a spray, an elastomeric device, a wipe, a lotion, an ointment, a cream, a gel or combinations thereof.

Abstract: A method for creating an antivenom for snake bites comprising obtaining the venom from at least one poisonous snake, obtaining an adult ratite bird, injecting the adult ratite bird with the venom in appropriate amounts at appropriate intervals such that the ratite bird develops antibodies to the venom, extracting blood from the bird or harvesting an egg from the inoculated ratite and removing the desired antibodies. The desired antibodies can be used to produce a antiserum containing antibodies to the venom.

Abstract: The present formulation is an analgesic, anesthetic and anti-pruritic formulation with from about 10.0 wt % to about 75.0 wt % Emu oil; from about 10.0 wt % to about 33.0 wt % benzyl alcohol; from about 0.25 wt % to about 5.0 wt % allantoin; from about 0.1 wt % to about 5.0 wt % methylparaben; from about 0.1 wt % to about 2.0 wt % propylparaben; and from about 0.5 wt % to about 4.0 wt % of lidocaine, wherein the formulation is adapted to inhibit microbial activity from Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus, Candida albicans, Streptococcus agalactiae or combinations thereof, and wherein the lidocaine relieves pain on the epidermis of humans and animals of skin irritations, wounds, or burns.

Abstract: The invention is a method and supplement for treatment of symptoms of Alzheimer's disease, dementia, depression, and combination thereof, comprising: from about 20 wt % to about 70 wt % emu oil, wherein the emu oil further comprises from about 1 wt % to about 12 wt % linolenic acid; from about 5 wt % to about 30 wt % l-arginine; from about 5 wt % to about 30 wt % pyroglutamate; from about 0.5. wt % to about 20 wt % B-12 methylcobalamin; and from about 0.5 wt % to about 20 wt % calcium, wherein the supplement is adapted for crossing a blood brain barrier, and for fortification of phospholipids in neurotransmitters of a brain to increase cell proliferation for treatment of symptoms of Alzheimer's disease, dementia, depression, and combinations thereof.

Abstract: Methods and compositions for treating skin ailments are described herein. Embodiments of the invention include a therapeutic composition. The thereapeutic composition is adapted for cleansing and treating skin and further includes an emu oil based composition. The emu oil based composition includes from about 20 wt. % to about 75 wt. % of refined sterilized emu oil, from about 0.01 wt. % to about 33 wt. % of one or more aromatic alcohols, from about 10 wt. % to about 25 wt. % of one or more benzoic acids, from about 0.2 wt. % to about 2.0 wt. % of allantoin, from about 0.025 wt. % to about 1.25 wt. % of methylparaben, from about 1.0 wt. % to about 13.0 wt. % of one or more alkyl esters and from about 0.01 wt. % to about 0.30 wt. % of propylparaben. Embodiments of the invention further include a composition including an aqeous emu oil based composition, wherein the aqueous emu oil based composition is adapted for cleansing and treating skin. Embodiments of the invention further include an absorbent article.

Abstract: An elastomeric article is described herein. The elastomeric article generally includes an elastomeric substrate, the elastomeric substrate including a first side and a second side, wherein the second side is opposite the first side. The elastomeric substrate further includes an absorbent layer flexibly bonded to at least a first portion of the first side. The absorbent layer includes an emu oil based composition. The elastomeric article further includes an adhesive composition applied to at least a second portion of the first side, the second portion occupying a different area of the elastomeric substruate than the first portion. The emu oil based composition includes from about 20 wt. % to about 75 wt. % of refined sterilized emu oil, from about 10 wt. % to about 33 wt. % of one or more aromatic alcohols, from about 10 wt. % to about 25 wt. % of one or more benzoic acids, from about 0.2 wt. % to about 2.0 wt. % of allantoin, from about 0.025 wt. % to about 1.25 wt. % of methylparaben, from about 1.0 wt.

Abstract: The invention is a method for creating a vaccine, an anti-venom for snake bites, and an anti-venom for spider bites in an adult ratite bird by obtaining at least one poisonous snake, harvesting venom of the snakes, obtaining an adult ratite bird, injecting the adult ratite bird with the venom in appropriate amounts at appropriate intervals, extracting blood from the bird or harvesting an egg from the inoculated ratite, removing desired antibodies, and using desired antibodies and make an antiserum containing antibodies to the venom.

Abstract: An analgesic, anesthetic and antipruritic formulation is provided containing 0.01 to 13 wt % alkyl esters; and 20 to 70 wt % Emu oil; 10 to 33 wt % benzyl alcohol; 10 to 33 wt % benzoin; 0.2 to 2 wt % allantoin; 0.25 to 1.25 wt % methylparaben and 0.01 to 0.30 wt % propylparaben. The formulation may be formulated as a spray or transdermal formula. The formulation may be used for treatment of chronic cutaneous ulcers and burn wounds.